Skip to main content

Table 1 Patients’ characteristics

From: Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients

 

Total

Group D

Group A

Group P

P value

N

44

12

14

18

 

Sex (m/f)

30/14

9/3

9/5

12/6

0.829

Age (mean ± SD)

70.8 ± 11.8

69.6 ± 14.3

74.1 ± 12.1

69.1 ± 9.8

0.335

 (median)

72.0

69.5

80.0

70.5

 

Hypertension

68.2%

66.7%

50%

83.3%

0.132

Dyslipidemia

29.5%

8.3%

28.6%

44.4%

0.104

Diabetes

38.6%

33.3%

21.4%

55.6%

0.131

Atrial fibrillation

34.1%

58.3%

57.1%

0%

< 0.001

Smoking

54.5%

66.7%

57.1%

44.4%

0.475

Stroke subtype (n)

    

< 0.001

 CE

23

9

14

0

 

 LAA

10

2

0

8

 

 SVO

11

1

0

10

 
  1. CE cardioembolism, LAA large artery atherothrombosis, SAO small vessel occlusion